Objective We clarified the clinical characteristics of patients with pulmonary nontuberculous mycobacterial (NTM) disease complicated by pneumothorax. Methods We retrospectively selected 220 patients who satisfied the diagnostic criteria for NTM disease proposed by the American Thoracic Society (ATS). Nine patients with pulmonary NTM disease were complicated with pneumothorax. We investigated the patients' background, laboratory findings, radiological findings, treatment and prognoses. Results There were nine patients, including six men and three women, with a mean age of 73.2 years. Seven patients had underlying respiratory diseases such as chronic obstructive pulmonary disease (COPD) excluding pulmonary NTM disease. The causative microorganisms was Mycobacterium avium in four patients, M. intracellulare in four patients, and M. kansasii in one patient. Regarding the radiological findings, pneumothorax was recognized in the right lung in five patients, in the left lung in three patients, and in both lungs heterogeneously in one patient. Although most patients exhibited multiple cavities and extensive lesions over the unilateral lung fields, three patients were simultaneously diagnosed with pulmonary NTM disease at the onset of pneumothorax. As for treatment, thoracic drainage was performed in seven patients, while one patient was advised only to rest and one patient required both thoracic drainage and surgery. The responses to the treatment was poor in each case, and five patients died due to pneumonia or heart failure. Conclusion In this study, the rate of pneumothorax complications in the patients with pulmonary NTM disease (4.1%) was higher than that of other reports. The responses to treatment, and prognoses were poor due to the presence of other complications.
Introduction
Since the diagnostic guidelines of pulmonary nontuberculous mycobacterial (NTM) disease were proposed by the American Thoracic Society (ATS) in 2007 (1) , the number of patients with pulmonary NTM disease has been increasing in Japan (2) . There are several case reports of pneumothorax complications in patients with pulmonary NTM disease (3) (4) (5) ; only one study regarding the clinical features of pneumothorax in patients with pulmonary NTM disease in Japan has been published (6) . The occurrence pf pneumothorax complications in patients with pulmonary NTM disease and pleuritis was previously rare compared to that observed in patients with pulmonary tuberculosis (TB). In a previous study, the frequency of pneumothorax complications in patients with pulmonary TB was reported to be 1.5% (7) , while that in patients with pulmonary NTM disease is approximately 2.3% (6) .
We recently experienced several refractory pulmonary NTM disease patients with pneumothorax at our hospital. Therefore, we retrospectively clarified the clinical character- 
Materials and Methods
This study was approved by the institutional review board of our hospital. Obtaining informed consent from each patient was not required because all data were collected retrospectively. We retrospectively selected 220 patients with pulmonary NTM disease who satisfied the diagnostic criteria for ATS (1) and were treated at our hospital between January 2003 and October 2012. We retrospectively investigated the backgrounds, laboratory findings, radiological findings, treatments, and prognoses of the patients with pulmonary NTM disease complicated by pneumothorax (nine patients) and those without pneumothorax (211 patients).
All data for the patients were drawn from charts, which included age, sex, smoking history, past medical history, and the duration from the definitive diagnosis of pulmonary NTM disease to the onset of pneumothorax. Laboratory findings such as the levels of total protein and albumin, which reflect nutritional conditions, and microbiological findings, such as causative microorganisms, as well as the results of smear and culture tests for acid-fast bacilli, were reviewed. Concerning the detection of complication of pneumothorax, we performed chest radiography and/or computed tomography (CT) during the follow-up period for as long as possible. Radiological findings, such as bronchiectatic changes, the presence of cavities, the site of the lesion, extension of the lesion (1: within one-third of the unilateral lung field, 2: within the unilateral lung field, 3: over the unilateral lung field) for pulmonary NTM disease, lesion laterality and pleuritis as a complication of pneumothorax, were also reviewed. All radiological findings were evaluated on chest CT by several pulmonologists. In terms of treatment, the medications used to treat pulmonary NTM disease and the therapy administered to treat pneumothorax and recurrence of pneumothorax were reviewed. Long-term follow-up was provided for these patients in order to investigate the prognosis. The duration of follow-up ranged from admission to nine years and chest radiographs and/or CT were assessed every three months, six months, or one year.
Statistical analysis
All statistical analyses were performed using the Statview software program Version 5.0 (SAS institute, Cary, North Carolina, USA).
Results
The clinical findings of the patients with pulmonary NTM disease complicated with pneumothorax are shown in Table 1. Nine patients (4.1%) (95% confidence interval (CI): 3.9-4.3%) with pulmonary NTM disease were complicated Rt (1) Lt (1) Lt (1) Rt (1) Rt (1) Rt (1) Rt (1) Lt ( with pneumothorax. The mean age was 73.2 years, and these patients included six men and three women. Seven patients had a history of smoking. All patients had underlying diseases, while seven patients had underlying respiratory diseases, such as chronic obstructive pulmonary disease (COPD) and/or pneumoconiosis, excluding pulmonary NTM disease. The nutritional status, as reflected by the albumin level, was poor, except in the patients without underlying diseases.
Concerning the microbiological findings of pulmonary NTM disease, the causative microorganisms consisted of Mycobacterium avium in four patients, Mycobacterium intracellulare in four patients, and M. kansasii in one pateint, respectively. Anti-NTM treatment including clarithromycin (CAM) was prescribed in five patients at the onset of pneumothorax. Regarding the radiological findings, eight patients had multiple cavity lesions related to the appearance of pneumothorax. Lesions caused by pulmonary NTM disease existed over the unilateral lung field in six patients and bilaterally in eight patients. One patient exhibited a solitary nodular shadow (small lesion) without cavities due to pulmonary Mycobacterium avium complex (MAC) disease. He was admitted to our hospital for pneumothorax treatment and afterwards diagnosed with pulmonary MAC disease following resection to differentiate the diagnosis from lung cancer.
The clinical findings of pneumothorax complicated by pulmonary NTM disease are shown in Table 2 . The frequency of pneumothorax was four episodes in one patient, and one episode in eight patients. The pneumothorax was located in the right lung in five patients, the left lung in three pateints, and both lungs in one pateint. The duration of pneumothorax onset after the diagnosis of pulmonary NTM disease ranged from three to 31 months in six patients, while both the diagnosis of pulmonary NTM disease and pneumothorax onset appeared at the same time in three patients. Complication with pleuritis or empyema in the patients with pneumothorax was confirmed in three cases. Concerning pneumothorax treatment, thoracic drainage was performed in eight patients and rest only was advised for one patient. The pneumothorax improved in four patients and was incurable in five patients. The final outcome of pulmonary NTM disease complicated by pneumothorax was death due to pneumonia in five patients, while four patients survived from five months to seven years. The clinical findings of the patients by pulmonary NTM disease complicated with pneumothorax (nine patients) and those without pneumothorax (211 patients) are shown in Table 3. Although we were unable to perform statistical comparisons between the two groups because there was a small number of patients with pulmonary NTM disease complicated by pneumothorax, we found the characteristic findings of the patients with pulmonary NTM disease complicated by pneumothorax to be as follows: 1. many patients were eld- erly men and had underlying diseases, such as COPD, 2. many patients exhibited extensive bilateral lesions and lesions over the unilateral lung field, 3. the mortality rate was high (56%).
Discussion
Although there are case reports concerning patients with pulmonary NTM disease complicated by pneumothorax and/ or pleuritis (3-6, 8, 9) , few studies have analyzed many patients with pulmonary NTM disease clinically complicated by either pneumothorax or pleuritis (6, 8) . In a previous study (6) , the complication rate of pneumothorax in patients with pulmonary NTM disease was low (2.3%) compared with that observed in our study (4.1%). Because the number of patients with pulmonary NTM disease may not be the same due to differences in investigation methods, there may be differences in the complication rate of pneumothorax. The characteristic findings of this study were as follows: 1) many patients complicated with pneumothorax were men (6/ 9) and had a history of smoking (7/9) compared to that observed in previous reports (1), and five of nine patients had COPD as an underlying disease, while the radiological findings on chest CT showed moderate or severe emphysematous changes; 2) all patients, except the patient in case 10, exhibited extensive lesions and multiple cavities due to pulmonary NTM disease. We speculate that the development of pneumothorax is related to the coexistence of other underlying respiratory diseases such as COPD or pneumoconiosis with pulmonary NTM disease, based on the results of this study. Although anti-NTM treatment was administered in five patients, the abnormal shadows due to pulmonary NTM disease, especially MAC disease, did not improve and pneumothorax appeared because the clinical effectiveness was not inadwquate (10) .
In order to identify the characteristic findings, we compared the clinical findings of the patients with pulmonary NTM disease complicated by pneumothorax with those of the patients without pneumothorax in this study. Consequently, most patients with pulmonary NTM disease complicated by pneumothorax exhibited different clinical characteristics such as elderly men with an underlying disease (COPD), extensive lesions over the unilateral lung field in the radiological findings, a poor response to medical or surgical treatment and a poor prognosis among those with pulmonary MAC disease without pneumothorax. These findings resemble those of the report by Hagiwara et al. (6) .
Concerning the treatment for pneumothorax complicated by pulmonary NTM disease, thoracic drainage was performed in all patients except in the patient in case 9. However, the pneumothorax relapsed after thoracic drainage in one patient (11%). Because most patients had moderate or severe pulmonary NTM disease, the pneumothorax was incurable, even with treatment, in six patients (67%). This was possibly because the patients with pulmonary MAC disease also exhibited a poorer response to antituberculous treatment compared to those with pulmonary tuberculosis. Meanwhile, three of the nine patients with pulmonary NTM disease were simultaneously complicated with both pneumothorax and pleuritis due to NTM in our study. In previous reports, although both pneumothorax and pleuritis due to NTM sometimes occurred in patients with pulmonary NTM disease (6, 8) , the treatment response to these complications was poor. In addition, all patients in our study were incurable despite the administration of thoracic drainage. The final outcomes of the patients with pulmonary NTM disease complicated by pneumothorax were poor (mortality rate: 56%); however, all patients died due to other complications (pneumonia or heart failure) and not due to worsening of pulmonary NTM disease.
There are a few limitations associated with this study. First, because we investigated only a small number of patients with pulmonary NTM disease in one hospital in a restricted area (Okayama), large-scale studies including several hospitals in Japan should be perform in order to obtain an accurate complication rate for the development of pneumothorax in patients with pulmonary NTM disease. Second, although we retrospectively investigated the follow-up period in many patients with pulmonary NTM disease for as long as possible, we were unable to completely assess all patients. Therefore, the complication rate of pneumothorax in patients with pulmonary NTM disease reported in this study may not be correct.
In conclusion, we confirmed that pneumothorax complicated by pulmonary NTM disease primarily occurs during the advanced stage of pulmonary NTM disease and coexists with other underlying respiratory diseases. Therefore, it was difficult to improve the condition of the pneumothorax, even with surgical treatment, in this study. Although the direct cause of death was due to complications other than those of pneumothorax in the patients with pulmonary NTM disease, clinicians must be careful regarding the possibility for complications of pneumothorax during the follow-up period in patients with both pulmonary NTM disease and other underlying pulmonary diseases.
The authors state that they have no Conflict of Interest (COI).
